Navigation Links
Bovine respiratory disease
Date:3/5/2010

average number of times an animal is treated for BRD by one treatment would result in a nearly $9 million savings to Oklahoma feedlot cattle producers."

Few studies have documented the economic effect of BRD from incidence of the disease through harvest, and especially the impact of BRD on acceptability of the final product as determined by consumers.

"Demand for higher-quality products and an increase in value-based marketing highlight the importance of research aimed at increasing beef producers' awareness of health management practices that have the potential to increase profitability and beef product quality," said Ron Kensinger, head of OSU's department of animal science.

Kensinger added the research is representative of the importance OSU's Division of Agricultural Sciences and Natural Resources places on its land-grant mission to provide science-based solutions to concerns and issues vital to enhancing the quality of life for people throughout Oklahoma and the region.

"Many of our complex problems in animal agriculture today require interdisciplinary teams to develop creative solutions," he said. "Clint is a great collaborator. The research efforts he leads compliment other research and extension efforts in the department to optimize use of forage by cattle, improve reproduction efficiency, advance quality assurance programs and other projects that are meant to help Oklahoma beef producers maximize their profit potential in sustainable ways."


'/>"/>

Contact: Donald Stotts
donald.stotts@okstate.edu
405-744-4079
Oklahoma State University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Bovine genome provides clues to possible new developments
2. Veterinary college researchers explore function of biofilm in bovine respiratory disease
3. Research leading to tools for managing bovine respiratory disease complex
4. Barn personnel experience higher-than-average rates of respiratory symptoms
5. Microbiologists find defense molecule that senses respiratory viruses
6. Fruit and vegetable intake in pregnant women reduces risk of upper respiratory tract infection
7. Malfunction of the respiratory epithelium is a cause of allergy?
8. Prolonged respiratory problems for oil spill clean-up volunteers
9. McGill, Quebec biotech firm partner for new bone-disease treatment
10. New way to control disease-spreading mosquitoes: Make them hold their urine
11. New University of Colorado paper shows novel way to study human inflammatory disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... , June 23, 2015  Crossmatch™, a ... authentication solutions, today announced enhanced functionality of its ... solution.  The enhancements build on the native ... DigitalPersona Altus platform and provide expanded mobile ... In today,s environment of increasing cyber-attacks ...
(Date:6/17/2015)... Maryland , and HILDEN, Germany , ... QGEN ; Frankfurt Prime Standard: QIA) today launched new ... evidence in forensic laboratories in the United States ... solution to simultaneously analyze multiple key genomic markers (short tandem ... ® Quality Sensor to evaluate the quality of DNA ...
(Date:6/16/2015)... , June 16, 2015  With the increasing ... security remains a top concern. The recent compromise of ... the need for strong authentication within government agencies. ... a biometric one-time password (OTP) authenticator, has been submitted ... (FIPS) 140-2 Level 3 validation for tamper proofing. ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... developed a method to dramatically improve the longevity of ... motion of a single molecule as it travels through ... process called resonance energy transfer, which occurs when fluorescent ... will be reported at the 234th annual national American ...
... Staph Infections in Humans Including MRSA ... against Staphylococcus aureus, including methicillin-resistant strains, in mice ... in the August 2007 issue of the journal ... a highly flexible and potentially dangerous pathogen capable ...
... study in the August 21st issue of Current Biology, a ... evidence in support of the long-held notion that men and ... the researchers found that women really do prefer pinkor at ... we expected to find sex differences, we were surprised at ...
Cached Biology News:Clemson scientists shed light on molecules in living cells 2Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3Girls prefer pink, or at least a redder shade of blue 2
(Date:7/1/2015)... , July 1, 2015   Decision Resources ... cited advantages of Otezla are its oral administration, ... as reported by surveyed rheumatologists. Otezla was the ... the treatment of active psoriatic arthritis in ... standard of care includes conventional oral treatments including ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus ... the development of groundbreaking drugs to treat neurodegenerative ... today that Robert G. Miller , M.D., Director ... Sutter Health,s California Pacific Medical Center in San Francisco, ... Association for $1.5 million to help fund a ...
(Date:7/1/2015)... Wilmington, DE (PRWEB) , ... July 01, 2015 , ... ... to develop new ideas to lower the barriers to innovation in life sciences R&D. ... for up to two cash prizes of US$15,000 and a period of expert mentorship ...
(Date:7/1/2015)... ... July 01, 2015 , ... NEMA 4 (IP66) Medical ... new Medical Joysticks have an impermeable molecular barrier protection against bio-hazardous agents. ... that will increase healthcare worker safety and reduce financial costs. , CTI Electronics ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... - Strengthened Balance Sheet and Advancing Products in 2008 - ... 11:00 a.m. Eastern Time -, BRANFORD, Conn., Jan. 31 ... financial results for the,fourth quarter and fiscal year ended December ... the fourth quarter of 2007,of $11.0 million, or $0.20 per ...
... (Euronext: AMT), a leader in the field of ... plan of rotation to appoint independent,directors to its ... Mr. Philippe van Holle, Head of Celgene Europe ... of shareholders. Mr. Van Holle is expected to,replace ...
... FRANCISCO, Calif., Jan. 30 Monogram,Biosciences, Inc., (Nasdaq: ... on Thursday, February 7, 2008 at 4:30 p.m. (Eastern ... discuss the outlook for 2008.,The call will be hosted ... To participate in the live teleconference, please call ...
Cached Biology Technology:CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 2CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 3CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 4CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 5CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 6CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 7Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board 2Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board 3Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call 2